1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. News
  7. Press Releases
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
Delayed Quote. Delayed Swiss Exchange - 05/27 11:31:37 am
107.3 CHF   +4.38%
05/12ZUR ROSE GROUP : Jefferies keeps its Buy rating
MD
05/12ZUR ROSE GROUP : Gets a Buy rating from Baader Bank
MD
05/11ZUR ROSE GROUP : Buy rating from Warburg Research
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ZUR ROSE GROUP AG
04/28ZUR ROSE GROUP AG : Shareholders approve all proposals
EQ
04/20Zur Rose Group sees revenue perform as expected in the first quarter of 2022
EQ
04/19ZUR ROSE : Release April 2022
PU
04/06Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
EQ
03/28ZUR ROSE : Sustainability Report 2021
PU
03/28ZUR ROSE : Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO..
PU
03/24ZUR ROSE : Nachhaltigkeitsbericht 2021 (nur in Englisch verfügbar)
PU
03/24ZUR ROSE GROUP : Excellent starting position for e-prescriptions set up and ecosystem stra..
PU
03/24ZUR ROSE GROUP : Excellent starting position for e-prescriptions set up and ecosystem stra..
EQ
01/20ZUR ROSE GROUP : steady growth in a volatile market environment
EQ
01/19ZUR ROSE : Release December 2021
PU
01/10Zur Rose Group nominates Rongrong Hu as director
EQ
2021Zur Rose Group successfully completed capital increase from authorised capital and set..
EQ
2021Zur Rose Group decides on capital increase from authorised capital and starts accelerat..
EQ
2021ZUR ROSE : EHealth-Tec achieves first place in the TOP 100 competition
PU
2021Roche and the Zur Rose Group announce collaboration to offer innovative health journeys..
PU
2021ZUR ROSE : continues to grow strongly Ad hoc announcement pursuant to Art. 53 LR
PU
2021ZUR ROSE GROUP : Board of Directors nominates Walter Oberhänsli as Chairman and appoints W..
PU
2021ZUR ROSE : Health app Well heralds the future of healthcare
PU
2021ZUR ROSE : Presentation on the half-year results 2021
PU
2021ZUR ROSE : accelerates growth in second quarter with revenue up 26 per cent Ad hoc announc..
PU
2021ZUR ROSE : Half-Year Report 2021
PU
2021ZUR ROSE : accelerates growth in second quarter with revenue up 26 per cent
EQ
2021ZUR ROSE : Release June 2021
PU
2021ZUR ROSE GROUP STRENGTHENS GROUP MAN : Madhu Nutakki to become Chief Technology Officer
PU
2021ZUR ROSE GROUP STRENGTHENS GROUP MAN : Madhu Nutakki to become Chief Technology Officer Co..
PU
2021FASTER AND MORE SECURE ACCESS TO THE : Compatible software development kit for software pr..
PU
2021ANNUAL GENERAL MEETING OF ZUR ROSE G : Shareholders approve all proposals
PU
2021ANNUAL GENERAL MEETING OF ZUR ROSE G : Shareholders approve all proposals
EQ
2021DOCMORRIS EXPANDS MANAGEMENT TEAM : Dr. Ulrich Thomé is appointed Chief Strategy Officer
PU
2021ZUR ROSE : signals dynamic revenue development in the first quarter of 2021
PU
2021ZUR ROSE : signals dynamic revenue development in the first quarter of 2021
EQ
2021ZUR ROSE : Release March 2021
PU
2021ZUR ROSE : publishes invitation to the Annual General Meeting on 29 April 2021
PU
2021ZUR ROSE : publishes invitation to the Annual General Meeting on 29 April 2021
EQ
2021ZUR ROSE : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering ..
AQ
2021ZUR ROSE : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering ..
AQ
2021DOCMORRIS : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering..
AQ
2021ZUR ROSE : Novo Nordisk and Zur Rose Group - Introducing DocMorris Adipositas Care (Obesit..
AQ
2021ZUR ROSE : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering ..
AQ
2021ZUR ROSE : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering ..
PU
2021ZUR ROSE : Release December 2020
PU
2021ZUR ROSE : Präsentation zum Jahresergebnis 2020
PU
2021ZUR ROSE : further extends European market leadership and successfully implements healthca..
PU
2021ZUR ROSE : further extends European market leadership and successfully implements healthca..
EQ
2021DOCMORRIS GOES EUROPEAN : new branding for marketplaces in Spain and France
PU
2021ZUR ROSE : accelerates growth
PU
2021ZUR ROSE : accelerates growth
EQ
2021ZUR ROSE : vindicated after court finds CEO Walter Oberhänsli not guilty
PU
2021ZUR ROSE : vindicated after court finds CEO Walter Oberhänsli not guilty
EQ
2021ZUR ROSE : TeleClinic builds on market leadership in telemedicine
PU
2021COLLABORATION BETWEEN ZUR ROSE GROUP : The Zur Rose Group and Novo Nordisk combine their e..
PU
2020THE HEALTHCARE PLATFORM OF THE FUTUR : DocMorris+ is launched
PU
2020ZUR ROSE GROUP AG : Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his succes..
PU
2020NEW BRANDING FOR A NEW VISION : DocMorris
PU
2020ZUR ROSE GROUP : gematik awards tender for specialist e-prescription service - Zur Rose s..
EQ
2020ZUR ROSE GROUP : gematik awards tender for specialist e-prescription service - Zur Rose su..
PU
2020ZUR ROSE : Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthc..
PU
2020ZUR ROSE : accelerates growth in third quarter 2020
PU
2020ZUR ROSE : accelerates growth in third quarter 2020
EQ
2020ZUR ROSE : Alternative Performance Measures of Zur Rose Group - Release September 2020
PU
2020ZUR ROSE : and KPT together launch digital medicines assistant Medi+
PU
2020ZUR ROSE : and KPT together launch digital medicines assistant Medi+
EQ
2020ZUR ROSE : H1 2020 Results Conference Call Presentation
PU
2020ZUR ROSE : Präsentation zum Halbjahresbericht 2020
PU
2020ZUR ROSE : reinforces European market leadership by rigorously implementing the growth and..
PU
2020ZUR ROSE : Le groupe Zur Rose renforce sa position de leader du marché européen avec la mi..
PU
2020ZUR ROSE : reinforces European market leadership by rigorously implementing the growth and..
EQ
2020ZUR ROSE : successfully concluded acquisition of the e-commerce and diabetes activities of..
PU
2020ZUR ROSE : successfully concluded acquisition of the e-commerce and diabetes activities of..
EQ
2020ZUR ROSE : successfully concluded acquisition of TeleClinic
PU
2020ZUR ROSE : successfully concluded acquisition of TeleClinic
EQ
2020ZUR ROSE : successfully completed capital increase from authorized capital and sets placem..
PU
2020ZUR ROSE : successfully completed capital increase from authorized capital and sets placem..
EQ
2020ZUR ROSE : acquires TeleClinic, Germany's leading telemedicine provider
PU
1  2Next
Upcoming event on ZUR ROSE GROUP AG